Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Dianthus Therapeutics, Inc. /DE/ (DNTH) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Dianthus Therapeutics, Inc. /DE/ (DNTH), most recent 12 months reported: revenue $2.04M, net loss $192.25M, free cash flow -$155.71M. Latest balance sheet on file: liquid cash $886.81M. From SEC filings. Others in Pharmaceutical Preparations: VISTAGEN THERAPEUTICS, INC. · Korro Bio, Inc. · NORTHWEST BIOTHERAPEUTICS INC · CYCLERION THERAPEUTICS, INC. · ORAMED PHARMACEUTICALS INC. · Seres Therapeutics, Inc. · CANNAPHARMARX, INC. · Ovid Therapeutics Inc.

Stock screener

Watchlist